# Validation of Blood-Based Biomarkers in TACE-Treated Hepatocellular Carcinoma

> **NCT07414433** · — · NOT_YET_RECRUITING · sponsor: **University of Belgrade** · enrollment: 60 (estimated)

## Conditions studied

- Hepatocellular Carcinoma (HCC)
- Liver Neoplasms

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07414433
- **Lead sponsor:** University of Belgrade
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-03-01
- **Primary completion:** 2029-03-30
- **Final completion:** 2029-12-30
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2026-02-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07414433

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07414433, "Validation of Blood-Based Biomarkers in TACE-Treated Hepatocellular Carcinoma". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT07414433. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*